Related Experiment Video
Updated: Jul 9, 2025

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
The m6A reader YTHDF2 alleviates the inflammatory response by inhibiting IL-6R/JAK2/STAT1 pathway-mediated
Zhuo Zeng1, Yingying Lan1, Lijuan Zhang1
1Institute of Burn Research, State Key Laboratory of Trauma, Burns and Combined Injury, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing 400038, China.
Background:
Sepsis is a common severe complication in major burn victims and is characterized by a dysregulated systemic response to inflammation. YTH domain family 2 (YTHDF2), a well-studied N6-methyladenosine (m6A) reader that specifically recognizes and binds to m6A-modified transcripts to mediate their degradation, is connected to pathogenic and physiological processes in eukaryotes, but its effect on sepsis is still unknown. We aimed to discover the effects and mechanisms of YTHDF2 in sepsis.
Methods:
Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and western blot analyses were used to measure the expression of YTHDF2, the interleukin 6 receptor (IL-6R), high-mobility group box-1 (HMGB1), Janus kinase 2 (JAK2) and signal transducer and activator of transcription 1 (STAT1) under different in vitro conditions. Enzyme-linked immunosorbent assays were utilized to evaluate the expression of HMGB1, IL-6, IL-1β and tumor necrosis factor-α. To confirm that YTHDF2 specifically targets IL-6R mRNA, RNA immunoprecipitation and dual-luciferase reporter assays were performed. Finally, we utilized a mouse model of lipopolysaccharide (LPS)-induced sepsis to verify the effects of YTHDF2 in vivo.
Results:
According to our findings, YTHDF2 was expressed at a low level in peripheral blood mononuclear cells from septic mice and patients as well as in LPS-induced RAW264.7 cells. Overexpression of YTHDF2 alleviated the inflammatory response by inhibiting HMGB1 release and JAK2/STAT1 signalling in LPS-stimulated cells. Mechanistically, YTHDF2 suppressed JAK2/STAT1 signalling by directly recognizing the m6A-modified site in IL-6R and decreasing the stability of IL-6R mRNA, thereby inhibiting HMGB1 release. In vivo experiments showed that YTHDF2 played a protective role in septic mice by suppressing the IL-6R/JAK2/STAT1/HMGB1 axis.
Conclusions:
In summary, these findings demonstrate that YTHDF2 plays an essential role as an inhibitor of inflammation to reduce the release of HMGB1 by inhibiting the IL-6R/JAK2/STAT1 pathway, indicating that YTHDF2 is a novel target for therapeutic interventions in sepsis.
Insights
YTHDF2 acts as an inflammation inhibitor in sepsis by reducing HMGB1 release. This mechanism involves suppressing the IL-6R/JAK2/STAT1 pathway, highlighting YTHDF2 as a potential therapeutic target for sepsis.
Area of Science:
- Molecular Biology
- Immunology
- Biochemistry
Background:
- Sepsis is a severe complication in burn victims, characterized by a dysregulated inflammatory response.
- YTH domain family 2 (YTHDF2), an m6A reader, is involved in eukaryotic cellular processes, but its role in sepsis remains unexplored.
Purpose of the Study:
- To investigate the effects and underlying mechanisms of YTHDF2 in sepsis.
- To determine if YTHDF2 can serve as a therapeutic target for sepsis.
Main Methods:
- Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and western blot to assess protein and mRNA expression.
- Enzyme-linked immunosorbent assays (ELISAs) to measure inflammatory cytokine levels.
- RNA immunoprecipitation and dual-luciferase reporter assays to confirm YTHDF2 targeting of IL-6R mRNA.
- A mouse model of lipopolysaccharide (LPS)-induced sepsis to validate findings in vivo.
Main Results:
- YTHDF2 expression was found to be low in septic conditions (mice, patients, and LPS-induced cells).
- Overexpression of YTHDF2 reduced inflammation by inhibiting HMGB1 release and the JAK2/STAT1 signaling pathway in LPS-stimulated cells.
- YTHDF2 suppresses IL-6R mRNA stability, thereby inhibiting HMGB1 release and the IL-6R/JAK2/STAT1 axis, demonstrating a protective role in septic mice.
Conclusions:
- YTHDF2 acts as a crucial inhibitor of inflammation in sepsis.
- YTHDF2 reduces HMGB1 release by modulating the IL-6R/JAK2/STAT1 pathway.
- YTHDF2 represents a novel therapeutic target for sepsis interventions.
Related Concept Videos
The JAK-STAT Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
TGF - β Signaling Pathway
Regulation of Hematopoietic Stem Cells

